Purified compounds from marine organism sea pen induce apoptosis in human breast cancer cell MDA-MB-231 and cervical cancer cell Hela.

Marine organisms are an important source of chemical compounds which are appropriate for use as therapeutic agents. Among them, Sea pens produce valuable chemical compounds being used as anti-cancer drugs. The aim of this study was to investigate anti-cancer property of extracted and purified compounds from marine organism Sea pen and evaluate their effects on inducing of apoptosis. The extracts were prepared from dried colony of Virgularia gustaviana. The compounds (3ß)-Cholest,5en,3ol (cholesterol) (15 mg), Hexadecanoic acid (2.5 mg) and 2-Hexadecanol (10.7 mg) were identified by GC-MS and NMR. The cytotoxic effects of the compounds were evaluated on Hela and MDA-Mb-231 human cancer cell lines with MTT assay. Immunocytochemistry and Western Blot analyses were used to evaluate the expression of apoptosis related markers Caspase 3, Caspase 8, Bax and BCL2 in cancer cells after treating with three compounds. The purified compounds reduced viability of human breast cancer cell line MDA-MB-231 and human cervical cancer cell line Hela concentration-dependently. 2-Hexadecanol reduced significantly the viability of both cancer cell lines in comparison to the other purified compounds. Treatment of cancer cells with the three purified compounds increased the expression of caspase-3, caspase-8 and Bax proteins and decreased the relative Bcl-2/Bax ratio, demonstrating induction of apoptosis as possible mechanism of action. According to the results, three purified compounds inhibit the growth of cancer cells by inducing of apoptosis pathway; an effect which needs to be further investigated in the future studies.

Inducing Apoptosis of Cancer Cells Using Sea Pen Virgularia gustaviana Extract Which is Comparable to Cembrane Diterpene Sarcophine.

Marine Soft corals have frequently been studied in recent years because of their specific chemical compounds in tissue engineering and regenerative medicine. The aim of this study was to investigate anti-cancer property of extracted compound from Virgularia gustaviana and their effect on inducing of apoptosis. The extraction process was carried out with ethyl acetate for 5 days and the extract was separated by silica-gel column chromatography. The column was washed with n-hexane-ethyl acetate solvent at ratio of 10:0 to 0:10. Thin layer chromatography (TLC), High performance thin layer chromatography (HPTLC), high performance liquid chromatography (HPLC), and 13C NMR spectroscopy were used for qualitative identification of compounds. The viability of HeLa and MDA-MB-231 cancer cells was investigated using MTT assay at the concentrations of 25, 50, and 100 µL/mL of extracted compounds. Immunocytochemistry and Western Blot analyses were used to evaluate expression of apoptotic markers caspase-3 and caspase-8 in cancer cells after treating with effective fractions (based on viability of cancer cells) and the results were compared with Sarcophine. From ten isolated fractions (A-J), Retention time and Retention Factors (Rf) of fractions G, I, and J were the same as Sarcophine. Fraction G, I, and J dose-dependently decreased cancer cell viability compared to control group and Sarcophine. Treatment of cancer cells with the latest fraction increased expression of caspase-3 and caspase-8 demonstrating induction of apoptosis as possible mechanism of action. According to the results, the compounds extracted from Virgularia gustaviana inhibit the growth of cancer cells by inducing of apoptosis pathway; an effect which needs to be further investigated in the future studies.